Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Krailo

Showing results (121-130 of 161) with videos related to

Pageof 17
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 21, 2019
Study of Unilateral Retinoblastoma With and Without Histopathologic High-Risk Features and the Role of Adjuvant Chemotherapy: A Children's Oncology Group StudyPatricia Chévez-Barrios, Ralph C Eagle, Mark Krailo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 17, 2007
A phase I study of 17-allylaminogeldanamycin in relapsed/refractory pediatric patients with solid tumors: a Children's Oncology Group studyBrenda J Weigel, Susan M Blaney, Joel M Reid, et al.
Journal of Pediatric Surgery|March 28, 2015
Surveillance after initial surgery for Stage I pediatric and adolescent boys with malignant testicular germ cell tumors: Report from the Children's Oncology GroupFrederick J Rescorla, Jonathan H Ross, Deborah F Billmire, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 6, 2012
Phase II trial of trastuzumab in combination with cytotoxic chemotherapy for treatment of metastatic osteosarcoma with human epidermal growth factor receptor 2 overexpression: a report from the children's oncology groupDavid Ebb, Paul Meyers, Holcombe Grier, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 3, 2014
Revised risk classification for pediatric extracranial germ cell tumors based on 25 years of clinical trial data from the United Kingdom and United StatesA Lindsay Frazier, Juliet P Hale, Carlos Rodriguez-Galindo, et al.
Journal of the National Cancer Institute|April 6, 2026
Overlapping genetic etiology of pediatric and adult germ cell tumorsShannon M Sullivan, John Lane, Abigail Standafer, et al.
Neuro-Oncology Pediatrics|May 25, 2026
Outcomes following radiotherapy for atypical teratoid/rhabdoid tumor in combination with surgery and intensive chemotherapy: A report from Children's Oncology Group study ACNS0333Paul Aridgides, Anita Mahajan, Thomas E Merchant, et al.
International Journal of Radiation Oncology, Biology, Physics|October 27, 2022
Analysis of Local Control Outcomes and Clinical Prognostic Factors in Localized Pelvic Ewing Sarcoma Patients Treated With Radiation Therapy: A Report From the Children's Oncology GroupSafia K Ahmed, Brent G Witten, William S Harmsen, et al.
International Journal of Radiation Oncology, Biology, Physics|October 2, 2017
Identification of Patients With Localized Ewing Sarcoma at Higher Risk for Local Failure: A Report From the Children's Oncology GroupSafia K Ahmed, R Lor Randall, Steven G DuBois, et al.
European Journal of Cancer (Oxford, England : 1990)|July 9, 2022
Phase 2 study of anti-disialoganglioside antibody, dinutuximab, in combination with GM-CSF in patients with recurrent osteosarcoma: A report from the Children's Oncology GroupPooja Hingorani, Mark Krailo, Allen Buxton, et al.
Pageof 17

Showing results (121-130 of 161) with videos related to

Sort By:
Pageof 17
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 21, 2019
Study of Unilateral Retinoblastoma With and Without Histopathologic High-Risk Features and the Role of Adjuvant Chemotherapy: A Children's Oncology Group StudyPatricia Chévez-Barrios, Ralph C Eagle, Mark Krailo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 17, 2007
A phase I study of 17-allylaminogeldanamycin in relapsed/refractory pediatric patients with solid tumors: a Children's Oncology Group studyBrenda J Weigel, Susan M Blaney, Joel M Reid, et al.
Journal of Pediatric Surgery|March 28, 2015
Surveillance after initial surgery for Stage I pediatric and adolescent boys with malignant testicular germ cell tumors: Report from the Children's Oncology GroupFrederick J Rescorla, Jonathan H Ross, Deborah F Billmire, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 6, 2012
Phase II trial of trastuzumab in combination with cytotoxic chemotherapy for treatment of metastatic osteosarcoma with human epidermal growth factor receptor 2 overexpression: a report from the children's oncology groupDavid Ebb, Paul Meyers, Holcombe Grier, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 3, 2014
Revised risk classification for pediatric extracranial germ cell tumors based on 25 years of clinical trial data from the United Kingdom and United StatesA Lindsay Frazier, Juliet P Hale, Carlos Rodriguez-Galindo, et al.
Journal of the National Cancer Institute|April 6, 2026
Overlapping genetic etiology of pediatric and adult germ cell tumorsShannon M Sullivan, John Lane, Abigail Standafer, et al.
Neuro-Oncology Pediatrics|May 25, 2026
Outcomes following radiotherapy for atypical teratoid/rhabdoid tumor in combination with surgery and intensive chemotherapy: A report from Children's Oncology Group study ACNS0333Paul Aridgides, Anita Mahajan, Thomas E Merchant, et al.
International Journal of Radiation Oncology, Biology, Physics|October 27, 2022
Analysis of Local Control Outcomes and Clinical Prognostic Factors in Localized Pelvic Ewing Sarcoma Patients Treated With Radiation Therapy: A Report From the Children's Oncology GroupSafia K Ahmed, Brent G Witten, William S Harmsen, et al.
International Journal of Radiation Oncology, Biology, Physics|October 2, 2017
Identification of Patients With Localized Ewing Sarcoma at Higher Risk for Local Failure: A Report From the Children's Oncology GroupSafia K Ahmed, R Lor Randall, Steven G DuBois, et al.
European Journal of Cancer (Oxford, England : 1990)|July 9, 2022
Phase 2 study of anti-disialoganglioside antibody, dinutuximab, in combination with GM-CSF in patients with recurrent osteosarcoma: A report from the Children's Oncology GroupPooja Hingorani, Mark Krailo, Allen Buxton, et al.
Pageof 17